Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Autopedia Sukses Lestari Tbk (ASLC) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Autopedia Sukses Lestari Tbk
Tempo Scan Pacific Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Autopedia Sukses Lestari Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Autopedia Sukses Lestari Tbk trades at Rp60 (market cap 764.78B, 1.53M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,470 (market cap 11.23T, 699.1K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 14.7× Autopedia Sukses Lestari Tbk's market cap, and Autopedia Sukses Lestari Tbk is more actively traded (1.53M versus 699.1K). Which is the better fit depends on your goals.

ASLCTSPC
Market Cap
764.78B11.23T
Volume
1.53M699.1K
Lot
15.34K6.99K
Turnover
91.29M1.75B
Average Price
59.492,496.22
Value
91.29M1.75B
Indicative Equilibrium Price
602,470
Indicative Equilibrium Volume
1.01K90

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASLC
View details
TSPC
View details

About Autopedia Sukses Lestari Tbk

PT Autopedia Sukses Lestari Tbk (formerly PT Adi Sarana Lelang) (the Company ) was established based on the notarial deed No. 93 of Dr. Irawan Soerodjo S.H., M.Si dated November 18, 2013. The Company started its commercial operations in 2014. The Company parent and ultimate parentcompany are PT Adi Sarana Armada Tbk and PT Adi Dinamika Investindo, respectively.

Read more on ASLC

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC